Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.60 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.60 |
| ▸ | SRD5A2 | P31213 | 12/20 | 0.94 |
| ▸ | TSHR | P16473 | 3/20 | 0.75 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA3 | P07451 | 1/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.60 |
| ▸ | CA6 | P23280 | 1/20 | 0.60 |
| ▸ | CA5A | P35218 | 1/20 | 0.60 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.60 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | DAO | P14920 | 1/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9236217 | 1.00 | SRD5A2 (0.94) | SRD5A2TSHRTP53CA1CA2 | |
| SCHEMBL69729 | 0.97 | SRD5A2 (1.00) | SRD5A2TSHRTP53CA1CA2 | |
| SCHEMBL2407327 | 0.97 | SRD5A2 (1.00) | SRD5A2TSHRTP53CA1CA2 | |
| SCHEMBL29013646 | 0.94 | SRD5A2 (0.94) | SRD5A2TSHRTP53CA1CA2 | |
| Bromide SCHEMBL21332117 | 0.94 | SRD5A2 (0.94) | SRD5A2TSHRTP53CA1CA2 | |
| SCHEMBL11598432 | 0.94 | SRD5A2 (0.94) | SRD5A2TSHRTP53CA1CA2 | |
| Bromide SCHEMBL16429424 | 0.94 | SRD5A2 (0.94) | SRD5A2TSHRTP53CA1CA2 | |
| Potassium SCHEMBL30444322 | 0.94 | SRD5A2 (0.94) | SRD5A2TSHRTP53CA1CA2 | |
| Hydrochloric Acid SCHEMBL1302150 | 0.92 | SRD5A2 (0.95) | SRD5A2TSHRTP53ALDH1A1DAO | |
| Terephthalic Acid SCHEMBL5083220 | 0.90 | TSHR (0.92) | SRD5A2TSHRTP53CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4137218-A | MOLDING MATERIALS | ALLIED CHEMICAL CORPORATION (US) | 1979-01-30 | — | — | US | claimed |
| EP-2498136-B1 | Intermediate transfer belt and image forming apparatus using the same | RICOH CO LTD (JP) | 2018-05-02 | — | — | EP | disclosed |
| US-9321017-B2 | Gas-separation membrane | NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) | 2016-04-26 | — | — | US | disclosed |
| US-20150033945-A1 | GAS-SEPARATION MEMBRANE | NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) | 2015-02-05 | — | — | US | disclosed |
| US-8521073-B2 | Intermediate transfer member and image forming apparatus using the same | RICOH COMPANY, LTD. (JP) | 2013-08-27 | — | — | US | disclosed |
| US-20120230740-A1 | INTERMEDIATE TRANSFER BELT AND IMAGE FORMING APPARATUS USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| EP-2498136-A1 | Intermediate transfer belt and image forming apparatus using the same | Ricoh Company, Ltd. (JP) | 2012-09-12 | — | — | EP | disclosed |
| US-20120082488-A1 | INTERMEDIATE TRANSFER MEMBER AND IMAGE FORMING APPARATUS USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-04-05 | — | — | US | disclosed |
| US-20040063785-A1 | Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use | GUILFORD PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | disclosed |
| EP-1360167-A1 | SYMMETRICALLY DISUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING POLY (ADP-RIBOSE) GLYCOHYDROLASE, AND METHODS FOR THEIR USE | GUILFORD PHARMACEUTICALS INC. (US) | 2003-11-12 | — | — | EP | disclosed |
| US-20030181496-A1 | Pyrrole derivatives | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2003-09-25 | — | — | US | disclosed |
| US-20020132852-A1 | Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use | GUILFORD PHARMACEUTICALS, INC. | 2002-09-19 | — | — | US | disclosed |
| WO-2002057211-A1 | SYMMETRICALLY DISUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING POLY (ADP-RIBOSE) GLYCOHYDROLASE, AND METHODS FOR THEIR USE | GUILFORD PHARMACEUTICALS, INC. (US) | 2002-07-25 | — | — | WO | disclosed |
| US-4918153-A | Copoly(imidine-amide) | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 1990-04-17 | — | — | US | disclosed |
| EP-0162606-B1 | AROMATIC POLYTHIOETHERAMIDES AND PROCESS FOR THEIR PRODUCTION | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1989-01-25 | — | — | EP | disclosed |
| US-4785074-A | PROTECTIVE COATINGS, RELIEF IMAGES | CIBA-GEIGY CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
| US-4694061-A | POLYAMIDE(IMIDE)S CONTAINING BENZOPHENONE (DI-ORTRI)CARBOXYLIC ACID | CIBA-GEIGY CORPORATION (US) | 1987-09-15 | — | — | US | disclosed |
| US-4621134-A | Aromatic polythioetheramide | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1986-11-04 | — | — | US | disclosed |
| EP-0162606-A1 | Aromatic polythioetheramides and process for their production | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1985-11-27 | — | — | EP | disclosed |
| US-4137218-A | MOLDING MATERIALS | ALLIED CHEMICAL CORPORATION (US) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063785-A1 | Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use | PARG, PARP1, PARP11 | CA2 1802/4885DRD1 4740/4885SRD5A2 1817/4885 |
| US-20030181496-A1 | Pyrrole derivatives | NCOA1, PKD1, NR3C2 | CA2 1415/4885DRD1 870/4885SRD5A2 101/4885 |
| US-20020132852-A1 | Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use | PARG, PARP1, PARP11 | CA2 1802/4885DRD1 4740/4885SRD5A2 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.